Royal Bank of Canada’s Cytek Biosciences CTKB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $76K | Buy |
22,448
+2,991
| +15% | +$10.1K | ﹤0.01% | 5387 |
|
|
2025
Q1 | $78K | Sell |
19,457
-4,074
| -17% | -$16.3K | ﹤0.01% | 4999 |
|
|
2024
Q4 | $152K | Buy |
23,531
+11,343
| +93% | +$73.3K | ﹤0.01% | 4589 |
|
|
2024
Q3 | $68K | Buy |
12,188
+771
| +7% | +$4.3K | ﹤0.01% | 5096 |
|
|
2024
Q2 | $64K | Buy |
11,417
+7,203
| +171% | +$40.4K | ﹤0.01% | 5142 |
|
|
2024
Q1 | $28K | Sell |
4,214
-36,484
| -90% | -$242K | ﹤0.01% | 5328 |
|
|
2023
Q4 | $371K | Buy |
40,698
+25,140
| +162% | +$229K | ﹤0.01% | 4030 |
|
|
2023
Q3 | $86K | Buy |
15,558
+8,036
| +107% | +$44.4K | ﹤0.01% | 4993 |
|
|
2023
Q2 | $64K | Buy |
7,522
+1,078
| +17% | +$9.17K | ﹤0.01% | 5203 |
|
|
2023
Q1 | $60K | Sell |
6,444
-14,221
| -69% | -$132K | ﹤0.01% | 5143 |
|
|
2022
Q4 | $212K | Buy |
20,665
+18,591
| +896% | +$191K | ﹤0.01% | 4370 |
|
|
2022
Q3 | $30K | Buy |
2,074
+1,430
| +222% | +$20.7K | ﹤0.01% | 5486 |
|
|
2022
Q2 | $7K | Sell |
644
-5,351
| -89% | -$58.2K | ﹤0.01% | 6044 |
|
|
2022
Q1 | $65K | Buy |
5,995
+2,341
| +64% | +$25.4K | ﹤0.01% | 5438 |
|
|
2021
Q4 | $59K | Buy |
3,654
+1,811
| +98% | +$29.2K | ﹤0.01% | 5747 |
|
|
2021
Q3 | $40K | Buy |
+1,843
| New | +$40K | ﹤0.01% | 5767 |
|